Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Traing Upate, Refinancing Notice of Results

17 Oct 2022 07:00

RNS Number : 0181D CentralNic Group PLC 17 October 2022 160

This announcement contains insie information for the purposes of Article 7 of the Market Abuse Regulation (EU) 96/2014160as it forms part160of UK omestic law by virtue of the European Union (Withrawal) Act1602018 ("MAR"), an is isclose in accorance with the Company's obligations uner Article 17 of MAR.

160

160

17 October 2022

160

CentralNic160Group plc160

("CentralNic" or the "Company", or the "Group")160

8239160

Q3 2022 Traing Upate, Refinancing an Notice of Results

160160

Continue momentum with 66% organic growth, resulting in upgrae FY22 outlook

8239160

CentralNic160Group plc (AIM: CNIC), the global internet platform company that erives recurring revenues selling online presence an marketing services,160is please to provie an upate for the 9 months ening 30 September 2022. The positive traing momentum previously announce has continue, an the Company's organic growth has further accelerate uring the perio.

160

Traing Upate

160

The Company expects to report revenue of approximately USD1602 million, Net Revenue of at least USD 127m an Ajuste EBITDA1 of at least USD16061 million for the nine months ening 30 September 2022, an increase of 86%, 49% an 89% respectively. Ajuste EBITDA/Net Revenue ratio improve to 48% as compare to 38% in the same perio last year. Year-on-year organic growth2 for the trailing twelve months ening 30 September 2022 is estimate at c.66%. This outperformance has been riven preominantly by the growth of the Online Marketing Segment, which continues to win market share as a result of the ever-increasing eman for online customer acquisition services that are privacy-safe.

160

Cash increase to USD 83m at 30 September 2022 from USD 6m as160at16031 December 2021, reucing Net Debt 3 to c.USD 63m at 30 September 2022 (USD 81m at16031 December 2021), espite the partially ebt finance acquisition of VGL (EUR 21m ebt component) an the recent cash settle acquisition of Aporia (USD 11m), being testament to the strong cash conversion. Ajuste operating cash conversion is estimate at approximately 100%.160

160

While the Directors remain cognisant of the current global macro-economic environment, they now have confience that the Group will materially excee the current market expectations for the full year4.

160

Refinancing

Post the perio en, CentralNic has entere into a new Senior Facilities Agreement ("SFA") uner which USD 20 million of new ebt facilities will be provie by a synicate of six banks.

The new ebt facilities comprise a USD 10 million term loan ("TL") an a USD 100 million revolving creit facility ("RCF"). The TL will be use in part to refinance the existing EUR 126 million senior secure bons (for which a corresponing bon call notice is expecte to be issue in short orer) an repay rawings uner the Group's existing revolving creit facility.

The TL an RCF have an initial maturity ate of October 2026, with an option to exten by a further year. The borrowing cost of the facilities is etermine by CentralNic's net leverage, such that this will initially be 2.7% above SOFR, a notable reuction compare to the 7% above 3m EURIBOR for the senior secure bon it replaces. The Company intens to enter into an interest swap transaction to fix part of the variable interest component. The settlement of the payments is scheule to be complete by the en of October.160

Ben Crawfor, CEO of160CentralNic, sai: "CentralNic continues to buil momentum in the thir quarter against typical seasonal trens, with year-on-year organic growth now reaching a recor 66%, a further acceleration over the 62% reporte for the twelve-month perio ening 30 June 2022.

160

"This continue reliable financial performance has allowe us to refinance at a notably improve interest rate, with a pool of quality lening banks which have the means to provie ongoing support to CentralNic's growth strategy. We look forwar to the future with even greater confience."

160

Notice of Results

160

The Company160will publish its unauite interim report for the nine months ening 30 September 2022 on Monay, 22 November 2022.160

160

There will be a webinar / conference call for equity analysts at 9:30am UK on the ay of results, hoste by CEO Ben Crawfor an CFO Michael160Riel.160 Anyboy wishing to register shoul160contact Isabelle Smurfit at centralnic@secnewgate.co.uk160where further etails will be provie.

160

1 Parent, subsiiary an associate earnings before interest, tax, epreciation, amortisation, non-cash charges an non-core operating expenses. Non-core operating expenses inclue items relate primarily to acquisition, integration an other relate costs, which are not incurre as part of the unerlying traing performance of the Group, an which are therefore ajuste for, in line with Group policy.

2 Organic growth is calculate base on trailing twelve-month pro-forma revenue ajuste for acquire revenue, constant currency FX impact an non-recurring an non-cash items (c.USD 682m an c.USD 411m for the trailing twelve months ening 30 September 2022 an 30 September 2021 respectively)

3 Inclues gross cash, interest-bearing ebt, prepai finance costs an Mark-To-Market (MTM) for the bon heges

4 Analyst consensus of revenue an ajuste EBITDA for the financial year ening16031 Dec 2022160as of Sunay, 16 October 2022 is USD 626.6m160an160USD 72.m160respectively

The margin is a function of leverage an con be up to 3.% if Net Debt/EBITDA excees 2. the maximum leverage is 3.0x, subject to conitions

160

160

160

-Ens-160

160

For further information: 160

CentralNic Group Plc

Ben Crawfor, Chief Executive Officer

Don Balaasan, Group Managing Director

Michael Riel, Chief Financial Officer

160+44 (0) 203 388 0600

Zeus (NOMAD an Joint Broker)

Nick Cowles / Jamie Peel / James Eis (Investment Banking)

Dominic King160(Corporate Broking)

160

+44 (0) 161 831 112

+44 (0) 203 829 000

Berenberg (Joint Broker)

Mark Whitmore / Richar Anrews / Alix Mecklenburg-Solokoff160160160160160160160160160160160160160160160160160160160160160160160160160160

160

+44 (0) 20 3207 7800

SEC Newgate (for Meia)

Bob Huxfor / Isabelle Smurfit/ Max Richarson

160

160

+44 (0) 203 77 6880

centralnic@secnewgate.co.uk

160

About CentralNic Group plc160

CentralNic (AIM: CNIC) is a Lonon-base AIM-liste company which rives the growth of the global igital economy by eveloping an managing online marketplaces allowing businesses globally to buy subscriptions to omain names for websites an email, monetise their websites, an acquire customers online. It supplements its organic growth by ientifying an acquiring cash-generative businesses in its inustry with annuity revenue streams an exposure to growth markets an migrating them onto the CentralNic software an operating platforms.160

For more information please visit:160www.centralnicgroup.com160

160

This information is provie by RNS, the news service of the Lonon Stock Exchange. RNS is approve by the Financial Conuct Authority to act as a Primary Information Provier in the Unite Kingom. Terms an conitions relating to the use an istribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP aress to confirm compliance with the terms an conitions, to analyse how you engage with the information containe in this communication, an to share such analysis on an anonymise basis with others as part of our commercial services. For further information about how RNS an the Lonon Stock Exchange use the personal ata you provie us, please see our Privacy Policy.160 END160160TSTMFBRTMTMBBAT
Date   Source Headline
1st Sep 20237:01 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSAcquisition of Adrenalads
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:02 amRNSTransaction in Own Shares
14th Aug 20237:01 amRNSNotice of Capital Markets Day
14th Aug 20237:00 amRNSSIX MONTHS ENDED 30 JUNE 2023 FINANCIAL RESULTS
11th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSContinued Expansion with Key Partnerships
7th Aug 20237:00 amRNSTransaction in Own Shares
4th Aug 20238:31 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 20237:00 amRNSTransaction in Own Shares
31st Jul 20237:00 amRNSTransaction in Own Shares
27th Jul 20237:00 amRNSTransaction in Own Shares
26th Jul 20237:00 amRNSTransaction in Own Shares
25th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSH1 Trading update and Notice of Results
21st Jul 20237:00 amRNSTransaction in Own Shares
20th Jul 20238:22 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSTransaction in Own Shares
14th Jul 20238:23 amRNSTransaction in Own Shares
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSDirectors' Dealings
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSDirectors’ Dealings
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20239:50 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 202310:41 amRNSDirectors' Dealings
3rd Jul 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.